The Ministry of Health has advised laboratories and PHOs that COVID exit testing for repatriation to other countries pre-departure will not be funded by the NZ government from 22 June 2020.
People registering for repatriation flights departing NZ will be made aware of any requirements around pre-departure testing by the Ministry for Foreign Affairs and Trade (MFAT) and airlines.
Read information about the testing process below:
Travellers will contact their medical practice to arrange testing. Payment must be made directly to the medical practice for all associated costs of testing, including the laboratory analysis.
Time-frame for Testing and Results
Pre-departure testing must be requested on or before 72 hours from when the result is required (not flight departure time). If a traveller presents with less than 72 hours before they require their result they should be aware of the likelihood they will not make their flight.
Turnaround time for results can be improved if samples are sent directly to the laboratory (e.g. delivered by taxi or the passenger themselves) to Labtests, Specimen Services, 37-41 Carbine Rd, Mt Wellington. This option is available Monday to Saturday from 9am to 4pm. Do not call Labtests Urgent Couriers, this service is for clinically urgent samples only.
The price of the laboratory analysis is $120 + GST; this must be paid to the medical practice directly. The laboratory will invoice the medical practice for testing as per standard invoicing process.
Manual Request Form
Medical practices must include relevant details on the test request form such as “Pre-departure COVID-19 Test”, “Clearance” or “Travel” and include time and date of departure. This allows the laboratory to identify the purpose of testing.
If using eOrders, select “Novel Coronavirus” and in funding category select “Patient to pay” (second option as below).
By requesting COVID-19 testing individuals are providing their consent for results to be sent through to the national result repository. This is a Ministry of Health requirement for all notifiable diseases. There is no requirement for a separate consent form to be completed for this purpose.
For queries relating to the laboratory testing process please contact email@example.com